Radiotherapy and PD-L1 inhibition in metastatic NSCLC

Dirk De Ruysscher*

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

8 Citations (Web of Science)
Original languageEnglish
Pages (from-to)840-842
Number of pages3
JournalLancet oncology
Volume18
Issue number7
DOIs
Publication statusPublished - Jul 2017

Keywords

  • CELL LUNG-CANCER
  • IMMUNOTHERAPY
  • MECHANISMS
  • RADIATION
  • THERAPY

Cite this